Mahatma Gandhi Institute of Medical Sciences
8
1
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
13%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
A Hybrid Effectiveness/Implementation Trial of the International Guide for Monitoring Child Development
Role: collaborator
Registry Trial to Evaluate the Safety and Efficacy of Hyperthermia in Locally Advanced Cancers
Role: lead
Perception About Upper Limb Functional Recovery, Barriers & Use of Training Devices Among Indian Stroke Survivors.
Role: lead
Challenges Faced By Neurophysiotherapist While Consultation Through Tele-rehabilitation
Role: lead
Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study
Role: lead
Effectiveness of Perturbations Exercises in Improving Balance, Function and Mobility in Stroke Patients
Role: lead
B-type NAtriuretic Peptide In Critically Ill : A Multicentric Diagnostic Study (B-rAPID)
Role: lead
Anti-Depressants vs Physiotherapy in Management of Fibromyalgia
Role: lead
All 8 trials loaded